DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
17	多系統萎縮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04431713 (ClinicalTrials.gov)	September 16, 2020	29/5/2020	Exenatide Once-weekly as a Treatment for Multiple System Atrophy	An Open Label, Single Site, 48 Week, Randomised Controlled Trial Evaluating the Safety and Efficacy of Exenatide Once-weekly in the Treatment of Patients With Multiple System Atrophy	Multiple System Atrophy	Drug: Exenatide Pen Injector [Bydureon]	University College, London	NULL	Recruiting	30 Years	80 Years	All	50	Phase 2	United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04431713
(ClinicalTrials.gov)

September 16, 2020

29/5/2020

Exenatide Once-weekly as a Treatment for Multiple System Atrophy

An Open Label, Single Site, 48 Week, Randomised Controlled Trial Evaluating the Safety and Efficacy of Exenatide Once-weekly in the Treatment of Patients With Multiple System Atrophy

Multiple System Atrophy

Drug: Exenatide Pen Injector [Bydureon]

University College, London

NULL

Recruiting

30 Years

80 Years

All

Phase 2

United Kingdom